# A Study of Xeloda (Capecitabine) Plus Oxaliplatin in Patients With Colon Cancer

> **NCT00069121** · PHASE3 · COMPLETED · sponsor: **Hoffmann-La Roche** · enrollment: 1886 (actual)

## Conditions studied

- Colorectal Cancer

## Interventions

- **DRUG:** Capecitabine
- **DRUG:** Oxaliplatin
- **DRUG:** Leucovorin (LV)
- **DRUG:** 5-Fluorouracil (5-FU)

## Key facts

- **NCT ID:** NCT00069121
- **Lead sponsor:** Hoffmann-La Roche
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2003-04-18
- **Primary completion:** 2011-04-21
- **Final completion:** 2011-04-21
- **Target enrollment:** 1886 (ACTUAL)
- **Last updated:** 2020-03-06


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00069121

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00069121, "A Study of Xeloda (Capecitabine) Plus Oxaliplatin in Patients With Colon Cancer". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT00069121. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*